Nosema bombycis is a spore-forming parasite causing microsporidiosis in silkworm Bombyx mori. Methionine aminopeptidase 2 (MetAP2), an essential gene of N. bombycis, is a target for the anti-microsporidian drug Fumagillin, an antibiotic derived from Aspergillus fumigatus. In this study, a 1077 bp full-length cDNA of the MetAP2 gene of N. bombycis was cloned and characterized. Furthermore, the expression study of the MetAP2 gene revealed a ubiquitous expression during all the developmental stages of the silkworm B. mori. The phylogenetic analysis of the MetAP2 gene of N. bombycis revealed the MetAP2 gene sequences to be highly conserved in nature. The present study also includes the validation of the antimicrosporidian drug Fumagillin against the MetAP2 gene of N. bombycis. The findings revealed that Fumagilin-B could also suppress the N. bombycis multiplication in the silkworm B. mori, thereby proving the therapeutic role of Fumagillin against microsporidian infection. This is the first-ever report regarding the characterization of the MetAP2 gene in the Indian isolate of N. bombycis and also towards the usage of Fumagillin in the control of microsporidiosis in B. mori.
Introduction
In India, silk farming or sericulture is a labour-intensive and export-oriented agro-based industry. Silk production is severely hampered due to occurrence of various diseases caused by different microbial pathogens. Among them, pebrine is a highly mortal protozoan disease caused by Nosema bombycis (Microsporidia). Infection of this disease ranges from chronic to highly virulent nature. It is the only disease which comes from both primary/secondary infection and occurs during all the seasons. After the infection, silkworm larvae become inactive and slow in development leading to death. Thus, there is an urgent need to develop or improve the available disease control methods to protect the silk industry from heavy loss.
Recent research works indicated that it is possible to control microsporidiosis using derivatives of benzimidazoles such as albendazole (Grob 2003) as they are active against many species of microsporidia. Fumagillin, ovalicin, and their analogues bestatin and TNP-470 have been demonstrated to have anti-microsporidian activity in in vitro and animal models of microsporidiosis. Fumagillin is an irreversible inhibitor of methionine aminopeptidase type 2 (MetAP2). The in vitro activity and effect of the inhibitors bestatin and TNP-470 on this recombinant microsporidian MetAP2 was characterized (Zhang et al. 2005) . These drugs do not bind or inhibit the activity of methionine aminopeptidase type 1 (MetAP1) or other aminopeptidases (Alvarado et al. 2009 ). Studies have demonstrated that Fumagillin derivatives display tissue and species selectivity in their ability to inhibit MetAP2, suggesting that it should be possible to design selective MetAP2 inhibitors (Turk et al. 1998) . The reactive epoxide of Fumagillin was found to form a covalent bond with histidine in the active site of human MetAP2 . Application of Fumagillin to control nosemosis 1 3 386 Page 2 of 8 in honey bees has been successful. The study provides a new tool for the development of in vitro systems to screen candidate compounds for use as new therapeutic agents for the treatment of microsporidiosis in silkworm. Hence, it was proposed to identify, clone, and characterize the therapeutic target MetAP2 in Bombyx mori and study the effect of already reported anti-microsporidian drugs in controlling microsporidiosis in silkworm.
Materials and methods

Isolation of Nosema spores
A total of 100 bivoltine (CSR2) silkworm, Bombyx mori larvae infected with Nosema bombycis (NIK-5hm) at 0 day of fourth instar were utilized for the study. The N. bombycis spores were diluted to 10 8 spores/mL and fed to the silkworm. The silkworm larvae were reared till the emergence of moth and the spore was purified from the moth. The moths were macerated and ground using the mixer grinder and filtered through muslin cloth. The filtered spore suspension was washed 4-5 times with sterile-distilled water to remove the debris. Finally, the spores were laid over the percoll cushion and centrifuged at 10,000 rpm for 20 min. The pellet obtained contained the pure spores which were used for the extraction of DNA using a modified DNA extraction protocol (Reddy et al. 1999 ). The DNA extracted was dissolved in TE buffer, electrophoresed, quantified using Nanodrop, and used as a template for PCR analysis.
DNA isolation from infected tissue
Midgut tissues were dissected out at different hours of post-infection (hpi) in liquid nitrogen; genomic DNA was extracted using the modified shortcut DNA isolation protocol (modified at this laboratory). A small amount of tissue was excised from the silkworm and used for DNA extraction. The excised tissue or egg was placed in a microfuge tube and homogenized by addition of lysis buffer (0.1 M Tris cl, 0.01M EDTA, 1M Nacl) of about 500 µL and crushed using the micro pestle. The crushed tissue was briefly vortexed and centrifuged at 13,000 rpm for 5 min. The aqueous layer was transferred to a new microfuge tube, and an equal volume of freshly prepared phenol:chloroform:isoamyl alcohol (24:24:1) was added and the tube contents were mixed gently. The tube was centrifuged at 13,000 rpm for 5 min and the supernatant was transferred to a microfuge tube, and an equal volume of isopropanol was added and incubated at room temperature for 20 min followed by centrifugation at 13,000 rpm for 5 min to pellet the DNA. The pelleted DNA was washed with 70% ethanol and air dried. The dried pellet was dissolved in 50 µL of sterile-distilled water and stored at − 20 °C for further use. The extracted genomic DNA was used as a template in PCR reaction with primers designed were used to amplify MetAP2 gene.
Identification of MetAP2 gene
The detection of MetAP2 gene through PCR technique has already been reported in Nosema ceranae (Higes et al. 2011) . The N. ceranae MetAP2 gene sequence (XM_00299649) was BLAST searched with N. bombycis genome (Microsporidia DB: http://micro spori diadb .org) and a sequence coding for MetAP2 gene was retrieved from the database. The retrieved MetAP2 sequence was used to design forward and reverse primers using Primer3 program. Around six different primers targeting the full length of MetAP2 gene of N. bombycis were used for the study, and the position of the primers and the sequence were shown schematically in Fig.  S1 and Table 1 .
Cloning and characterization of MetAP2 gene
The presence of MetAP2 gene in N. bombycis-infected samples was confirmed by cloning and sequencing of PCR fragments using pGEM T easy vector. The plasmid DNA was then purified through DNA purification column (Promega) and used for sequencing at Eurofins Genomics India Pvt. Ltd., Bangalore. 
Multiple sequence alignment and phylogenetic analysis
The phylogenetic relationship of microsporidian N. bombycis MetAP2 gene with MetAP2 genes from other microsporidians was analyzed using the MEGA 6.1 (Kumar et al. 2004) . The N. bombycis MetAP2 gene was compared with the MetAP2 amino sequences of the nine microsporidian species, namely, N. apis (JQ927010), N. ceranae
, and E. hellem (AY224694). The multiple sequence alignment was performed using clustal W program.
RNA isolation and cDNA synthesis
The RNA was extracted from different tissues midgut, trachea, Malpighian tubules, ovary, fat body, and egg using TRIzol reagent (Invitrogen, USA). The first-strand cDNA was synthesized using DNase free RNA sample (2 µg) along with 1 µL random hexamer (Eurofins India Pvt Ltd, Bangalore) and 10 mM dNTP (1 µL) was added followed by incubation at 65 °C for 5 min. Finally, 5X reverse transcriptase buffer (4 µL), 5 mM DTT (2 µL), and Superscript III reverse transcriptase (Invitrogen, USA) (1 µL) were added to obtain a final volume of 20 µL. The reaction mixture was incubated at 42 °C for 60 min and the reaction was terminated by heating at 75 °C for 10 min according to the manufacturer's protocol.
Tissue-specific expression profile
The expression of MetAP2 in different tissues was analyzed using quantitative PCR (qPCR) with MetAP2 gene-specific primer. One microliter of first-strand cDNA was used in a 20 µL reaction mixture using the specific primers exclusively designed for qPCR on STRA TAG ENE Mx 3005P real-time PCR system. The experiment was performed in triplicate. The results were standardized to the expression level of the constitutive β actin gene. A non-template control (NTC) sample was also run to detect contamination.
Selection of drugs and in vivo toxicity test
A wide range of drugs have been evaluated for efficacy against microsporidia under in vitro and in vivo conditions, and Fumagillin continues to be the most effective. Fumagilin-B is the only available drug to treat Nosema disease in North America (Williams et al. 2011 ) and its usage is allowed at special circumstances in Spain and a few parts of Europe (Stevanovic et al. 2013 
Evaluation of anti-microsporidian activity
About 500 silkworms were infected with N. bombycis spores at a concentration of 1 × 10 8 spores/mL, and among them, three trays containing 100 silkworms each were treated with Fumagilin-B (2, 20, 120 mg/mL). The samples were collected at about 24 h interval for 5 days. The RNA was isolated followed by cDNA synthesis which was used for further analysis. The multiplication of N. bombycis in the infected and Fumagillin-treated silkworm was quantified using the expression of N. bombycis specific genes. Along with the MetAP2 gene, the polar tube protein and β-tubulin genes essential for N. bombycis infection were used for the study. A known concentration of tenfold serially diluted spore DNA samples was used as template to obtain the standard curve in an Agilent Stratagene Mx3005P qPCR instrument targeting the Nosema-specific β-tubulin gene. Standard curve was established by plotting the threshold cycle (Ct) on the Y-axis and the log of concentration on the X-axis, and is used to determine the concentration of the unknown samples. The spore load was determined by plotting the Ct value of infected and Fumagillin-treated silkworm genomic DNA samples.
Statistical analysis
The real-time expression data were subjected to descriptive statistical analysis and the significance of deference between infected and treated samples was tested using the analysis of variance, and p value of < 0.01 is considered statistically significant.
Results and discussion
The examination of the purified N. bombycis spores isolated from the silkworms through the microscope revealed that their morphology was in confirmation with the earlier report (Selvakumar et al. 2005) . Analysis of inoculated fourth instar larval samples revealed that the intensity of infection increased gradually as confirmed by microscopic examination and through the conventional PCR using the pathogenspecific primers. Methionine amino peptidases are metallo exopeptidases which catalyse the release of methionine from N-terminal amino acid of peptides and arylamides (Pandrea et al. 2005) . MetAP2 is the only known therapeutic target for the anti-microsporidian drug Fumagillin. Hence, the fulllength MetAP2 gene of N. bombycis was cloned and characterized, and used for constructing phylogenetic tree for comparison with other microsporidians infecting the insects and humans. The drug Fumagillin was validated against the MetAP2 gene of N. bombycis for controlling microsporidiosis in silkworms.
Cloning and characterization of MetAP2
This is the first report on the identification and characterization of methionine MetAP2 gene in N. bombycis. The MetAP2 gene primers were designed based on the MetAP2 gene sequence (XM_00299649) of N. ceranae, a microsporidian-infecting European honey bees. As shown in Fig. S1 , primers specific to the nucleotide sequence encoding for the MetAP2 of N. bombycis were used to amplify the MetAP2 gene. The amplicons with appropriate size confirmed the presence of MetAP2 gene in N. bombycis. The amplified N. bombycis MetAP2 gene fragments were cloned into TA cloning vector and the positive clones were sequenced. The sequence has been submitted to NCBI (KX820249). The ExPASy portal tool was used to confirm the open reading frame from the MetAP2 nucleotide sequence coding for a large ORF of 358 amino acids. The estimated isoelectric point of MetAP2 was found to be 5.75 and its molecular weight has been predicted to be 40.5 kDa. The major amino acids coded by MetAP2 gene were isoleucine (10%), lysine (7.8%), and threonine (7.3%) with 47 negatively charged and 41 positively charged residues. The atomic composition of the MetAP2 protein revealed it to be composed of 5691 atoms. The amino acids from number 59-354 were found to be conserved. The protein fold was found to contain both alpha helices and an anti-parallel beta sheet within two structurally similar domains that are thought to be derived from ancient gene duplication. The blast X analysis of the MetAP2 gene of N. bombycis revealed that no introns were present in the N. bombycis MetAP2 gene.
Phylogenetic tree analysis
The cloned MetAP2 sequence of the Indian isolate of N. bombycis was analyzed using Blastn and Blastp which confirmed that its DNA sequence had maximum homology with, N. ceranae, N. bombi, and N. apis. Neighborhood joining analysis revealed that the MetAP2 gene formed three major clusters with highly significant bootstrap values. The first group comprised of N. apis, N. ceranae, N. bombi, and N. bombycis; the second included E. intestinalis, and E. romaleae, E. hellem, E. cuniculi, and Ordospora colligata formed an outer group (Fig. 1) . Among the major clusters, the first group belonged to the human microsporidian pathogens, while the second group comprised of microsporidianinfecting insects. The second major cluster contains the three genotypes, namely, Vittaforma, Spraguea, and Vavraia.
Comparison of amino acid sequences of different microsporidians
The amino acid sequence alignment of nine microsporidian species (N. bombycis, N. ceranae, N. apis, E. cuniculi, N. bombi, E. intestinalis, E. hellem, and E. romaleae ) is shown in Fig. 2 . It is apparent from the sequence alignment that the nine microsporidian sequences are highly conserved between the amino acid segments of 66-112, 126-148, 155-168, 170-186, 201-214, 226-249, 288-299, 323-330, and 335-350 , and they lie inside the predicted active site. The acidic NH 2 -terminal domain of MetAP2 coordinates two zinc ions and is involved in the activity of MetAP2 responsible for the inhibition of phosphorylation of eIF2 by heme-regulated inhibitor kinase (Griffith et al. 1997) . The N. bombycis lacks this polylysine sequence at the NH 2 terminal end, thereby indicating that it is not involved in the inhibition of phosphorylation of eukaryotic initiation factor. It has already been reported that the MetAP1 gene lacks the carboxy terminal domain found between the active site Glu-243 and His-340 residues, thereby marking the specificity of Fumagillin towards MetAP2 (Katinka et al. 2001) . About 60% genetic distance was observed from the deduced amino acid sequence between N. bombycis and Nosema speciesinfecting insects (Table S1 ). The N. bombycis sequence was scavenged for conserved residues which play the critical role in binding of epoxide ring of Fumagillin. The amino acid residues Asp, Asp, Glu, His, and His were reported to be the highly conserved metal coordinating residues (Lowther et al. 1998) . The conserved region indicates that the Fumagillin inhibits the enzyme in a similar way as reported for the human enzyme (Molina et al. 2002) . Even though a higher genetic distance was calculated, all the microsporidian isolates infecting insects and humans shared the most common conserved regions of the active site.
Tissue-specific expression profile
The qPCR analysis revealed high expression of MetAP2 in the infected silkworm ovary followed by midgut, fat body, trachea, malpighian tubule, and egg where only slight expression was observed (Fig. 3) . The upregulation of MetAP2 gene in host ovary might be due to the stage at which the sample was collected, resulting in the transfer of the pathogen to its progeny via the egg. The mRNA transcript in egg might be due to the accumulation of MetAP2 mRNA in the ovary. It has already been reported that the expression of MetAP2 was upregulated immediately after infection and it is obvious that MetAP2 should also have a higher expression to activate MetAP2 gene of Nosema. To further confirm the expression of MetAP2, specific analysis was carried out at different time intervals and the expression was found to be higher at 120 hpi followed by 72 hpi (Fig. 4) . The MetAP2 gene of N. bombycis was found to be expressed ubiquitously in all the developmental stages of the infected silkworm (Fig S2) .
Effect of Fumagilin-B on N. bombycis
Earlier reports suggest that the Fumagillin binds to histidine in the active site of human MetAP2 (Klein and Folkers 2003) and the carboxy terminal domain found between the active site Glu-243 and His-340 residues is absent in MetAP1 (Katinka et al. 2001 ) marking its specificity towards MetAp2. The toxicity of Fumagillin reported in humans is due to the low selectivity of the drug between the microsporidian and human MetAP2 (Van der Heever et al. 2014) . Since microsporidia appear to lack MetAP1 and carry only a gene for MetAP2, Fumagillin would be a promising drug for targeting only the microsporidian MetAP2. The toxicity is negligible in silkworms, since they do not show any sequence homology with N. bombycis. The absence of MetAP1 would prevent microsporidia from compensating for the loss of MetAP2 activity when exposed to Fumagillin. Earlier reports have already determined that Fumagillin inhibits only MetAP2 protease activity of microsporidia and does not interfere with the host genes (Didier et al. 2006) . Phylogenetic analysis revealed that Fumagillin could be used as an anti-microsporidian drug against N. bombycis infecting silkworm B. mori. The efficacy of anti-microsporidian agent Fumagillin against N. bombycis was evaluated in our study. Bioassay analysis (cytotoxicity) was performed to confirm whether the selected concentration of compound Fumagillin is toxic or tolerable for the silkworms. Initially, four different concentrations of Fumagillin were selected, viz., 2, 20, 120, and 200 mg/mL per 100 larvae to study the anti-microsporidian activity. Each dose of Fumagilin-B was given orally to the healthy larvae on alternate days up to 120 hpi. The highest concentration of 200 mg/mL treated leaves was not consumed by the silkworms, whereas the silkworms treated with 120 mg/mL showed lethargic behavior. However, the silkworms treated with 2 and 20 mg/mL Fumagillin were at par with normal healthy silkworms without Fumagillin treatment, indicating that they did not produce any adverse effect on silkworm physiology. Hence, Fumagillin at three different concentrations were used to determine the effective dosage to control the N. bombycis infection in silkworms.
The efficacy of the drug Fumagillin in controlling the N. bombycis infection in the treated sample was compared with the untreated control through semi-quantitative and qPCR analysis. The results endorsed the effectiveness of Fumagillin in inhibiting the MetAP2 gene of N. bombycis infecting silkworms. The Fumagillin was administrated after 12 h of post-infection with N. bombycis spores. The N. bombycis multiplication was quantified using qPCR in Fumagillintreated and control-infected samples. The N. bombycis multiplication was determined at 24 hpi interval up to 120 hpi targeting the MetAP2 gene.
The effect of Fumagillin in N. bombycis-infected silkworms at five different time points by targeting MetAP2 gene is shown in Fig. 5a . The expression level of MetAP2 gene revealed increasing trend of multiplication up to 120 hpi. However, the Fumagillin treatment at different concentrations showed a significant decline in expression after 48 h after treatment, thereby indicating the suppression of N. bombycis multiplication. The treatment was given at three different doses 2, 20, and 120 mg/mL for 100 larvae. Among the three different doses, 20 mg/mL revealed a significant suppression of N. bombycis multiplication and the effect was consistently noticed at all time points. Though the treatment with the drug Fumagillin showed a significant decrease in target gene copies, it could not completely eliminate the pathogen from the host tissue. This finding indicates that Fumagillin treatment could significantly reduce the pathogen load but could not eliminate N. bombycis completely from the host tissue. Twenty mg/mL of Fumagilin-B was concluded to be the optimum dosage for controlling microsporidiosis with reduced symptoms and without affecting the silk production. The Fumagillin-treated silkworms were able to spin the cocoon, while the untreated batch failed to go for spinning. It was revealed that Fumagillin decreased the spore load drastically and delayed the spread of the disease. Even though Fumagillin inhibits N. bombycis to a greater extent by reducing the spore load inside the host, the drug administration should be done continuously to prevent the multiplication of the pathogen. The other two essential genes β-tubulin and polar tube protein 1 involved in host invasion were also found to be expressed relatively at a lower level from 48 h after treatment when compared to the untreated control (Fig. 5b, c) . The decline of spore load in the Fumagillin-treated sample was further confirmed by qPCR with the genomic DNA of the infected and treated silkworms using the β-tubulin gene of Nosema bombycis (Fig S3) . Our study indicated that Fumagilin-B could not completely eliminate the N. bombycis from the host. However, it could significantly suppress the multiplication of pathogen in the infected silkworms. Furthermore, this problem can be overcome through systematic formulation of the dosage and by developing appropriate application schedules. Our study validated the Nosema MetAP2 gene as a target for anti-microsporidian drug and will also help in designing new inhibitors against the microsporidians in near future. 
